IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR
批准号:
7369044
负责人:
JAY A LEVY
金额:
$1.89万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-02-28
中文摘要
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。感染艾滋病毒并保持健康10年以上的个人被视为长期幸存者。这些无症状的个体有很强的细胞介导的免疫反应,抑制HIV复制。当感染者发展成疾病时,这种活动就消失了。抗病毒反应是由分泌的CD8+细胞抗病毒因子(CAF)介导的,该因子通过HIV启动子阻断转录。CAF由来自这些健康感染者的CD8+细胞以低水平产生。这种蛋白质似乎不同于任何已知的细胞因子、趋化因子和人类生长因子。CAF鉴定最有可能通过蛋白质纯化和质谱法来实现。方法将健康hiv感染者的CD8+细胞培养在不含血清和白蛋白的培养基中。在实验室用标准程序测定液体的抗病毒活性。然后通过各种生化技术(包括离子交换、色谱和分级柱)对活性流体进行浓缩和分馏。具有富集CAF活性的馏分用二维凝胶分析,并用质谱法评估。到目前为止,我们已经能够证明CAF的分子大小约为50 kD。通过2D凝胶分析,至少有20个不同的点与CAF活性相关。质谱分析的研究正在进行中。这些蛋白质斑点是独特的含钙液体将进一步评估。通过质谱分析,我们希望能够鉴定介导这种抗hiv活性的蛋白质(CAF)。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Introduction Individuals who have been infected with HIV and remain healthy for over 10 years are considered long-term survivors. These asymptomatic individuals have a strong cell-mediated immune response that suppresses HIV replication. This activity is lost as the infected person advances to disease. The antiviral response is mediated by a secreted CD8+ cell antiviral factor (CAF) which blocks transcription via the HIV promoter. CAF is produced at low levels by CD8+ cells from these healthy infected individuals. The protein appears to be unlike any of the known cytokines, chemokines and human growth factors. CAF identification will most likely be achieved through protein purification and mass spectrometry. Methods CD8+ cells from healthy HIV-infected individuals are grown in culture medium lacking serum and where possible, albumin. Fluids are assayed for antiviral activity by standard procedures in the laboratory. Active fluids are then concentrated and fractionated by various biochemical techniques including ion exchange, chromatography, and by sizing columns Fractions with enriched CAF activity are analyzed by 2-D gel and evaluated by mass spectrometry. Results Thus far, we have been able to show that CAF has a molecular size of about 50 kD. By differential 2D gel analysis, there appears to be at least 20 different spots that are associated with CAF activity. Studies are in progress to analyzed by mass spectrometry. Those protein spots that are unique to CAF-containing fluids will be further evaluated. Discussion By mass spectrometry, we hope to be able to identify the protein (CAF) that mediates this anti-HIV activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a New Anti-HIV Immune Protein
-
批准号:9349402
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2017
-
负责人:JAY A LEVY
-
依托单位:
HIV Cure with CCr5 (-) Human IPS Hematopoietic Stem Cells
-
批准号:8659220
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2014
-
负责人:JAY A LEVY
-
依托单位:
HIV Cure with CCr5 (-) Human IPS Hematopoietic Stem Cells
-
批准号:9052116
-
项目类别:
-
资助金额:$69.77万
-
财政年份:2014
-
负责人:JAY A LEVY
-
依托单位:
HIV cure with CCR5 (-) human IPS hematopoietic stem cells
-
批准号:8470397
-
项目类别:
-
资助金额:$51.82万
-
财政年份:2012
-
负责人:JAY A LEVY
-
依托单位:
Protection from HIV Infection in Intravenous Drug Users
-
批准号:8012878
-
项目类别:
-
资助金额:$25.53万
-
财政年份:2010
-
负责人:JAY A LEVY
-
依托单位:
Protection from HIV Infection in Intravenous Drug Users
-
批准号:8100171
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2010
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:7894208
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2009
-
负责人:JAY A LEVY
-
依托单位:
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR
-
批准号:7724166
-
项目类别:
-
资助金额:$1.15万
-
财政年份:2008
-
负责人:JAY A LEVY
-
依托单位:
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR
-
批准号:7601815
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2007
-
负责人:JAY A LEVY
-
依托单位:
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR
-
批准号:7180932
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2005
-
负责人:JAY A LEVY
-
依托单位:
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR
-
批准号:6976620
-
项目类别:
-
资助金额:$3.89万
-
财政年份:2004
-
负责人:JAY A LEVY
-
依托单位:
Project 3 - MBSR & the Immune System in Early HIV Infection
-
批准号:6884431
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2004
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:7496465
-
项目类别:
-
资助金额:$54.28万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:6837659
-
项目类别:
-
资助金额:$63.98万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:6770071
-
项目类别:
-
资助金额:$62.12万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:7787097
-
项目类别:
-
资助金额:$72.15万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
20Years of HIV Research: From Discovery to Understanding
-
批准号:6571328
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:7628613
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:7338224
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
Role of Innate Immunity in Controlling HIV Infection
-
批准号:7338413
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2003
-
负责人:JAY A LEVY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖脂代谢重塑型金属多酚纳米药物促进CD8+ T细胞活化浸润增效PD-1抗体治疗三阴性乳腺癌的研究
-
批准号:2026JJ50635
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘芙蓉
-
依托单位:
前列腺癌CD8+ T细胞雄激素受体表达介导内分泌治疗耐药的机制研究
-
批准号:JCZRLH202601667
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Leptin通过调控MxA表达促进CD8+ T细胞活化参与白癜风发生发展的作用机制研究
-
批准号:2026JJ81680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张慧明
-
依托单位:
CD8+ T细胞衰老的代谢调控研究
-
批准号:JCZRQNA202600019
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
核B7-H3调控DKK4介导的CD8+ T细胞耗竭影响结直肠癌远处转移的机制研究
-
批准号:JCZRQNB202600082
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
“增强型”铜死亡纳米药物改善CD8+ T细胞耗竭用于腺导管腺癌免疫治疗的研究
-
批准号:JCZRLH202600099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肠道菌群来源的色氨酸代谢物通过芳香烃受体(AhR)调控NMO中枢CD8+ T细胞浸润的机制研究
-
批准号:2026JJ80630
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周娟
-
依托单位:
长链非编码RNA Malat1通过PTEN/TCF-1促进记忆CD8+ T细胞分化的机
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李保华
-
依托单位:
MHC-E限制性CD8+调节性T细胞抑制抗肿
瘤免疫反应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:王蕾
-
依托单位:
细胞凋亡抑制蛋白2通过激活PPAR通路促进黑色素瘤中CD8+ T细胞脂肪酸代谢及抗肿瘤效应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孙嘉政
-
依托单位: